Ascendis Pharma A/S (ASND) scores 31 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Avoid The estimated fair value is $154.18, representing a 29% premium to fair value. Quantitative score: 46/100. Qualitative score: 30/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.